Next Article in Journal
Diseases — the Reasons for a New Challenge in Open Access Medicine Research
Next Article in Special Issue
Trypanosomatid Aquaporins: Roles in Physiology and Drug Response
Previous Article in Journal / Special Issue
The Nervous System Cytoskeleton under Oxidative Stress
Article Menu

Export Article

Open AccessReview
Diseases 2013, 1(1), 51-72; doi:10.3390/diseases1010051

Effect of Cardio-Metabolic Risk Factors Clustering with or without Arterial Hypertension on Arterial Stiffness: A Narrative Review

Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, 15 Marmara St, Thessaloniki, 55132, Greece
*
Author to whom correspondence should be addressed.
Received: 20 June 2013 / Revised: 9 November 2013 / Accepted: 14 November 2013 / Published: 20 November 2013
(This article belongs to the Special Issue Feature Papers)
View Full-Text   |   Download PDF [299 KB, 27 November 2013; original version 20 November 2013]

Abstract

The clustering of cardio-metabolic risk factors, either when called metabolic syndrome (MetS) or not, substantially increases the risk of cardiovascular disease (CVD) and causes mortality. One of the possible mechanisms for this clustering's adverse effect is an increase in arterial stiffness (AS), and in high central aortic blood pressure (CABP), which are significant and independent CVD risk factors. Arterial hypertension was connected to AS long ago; however, other MetS components (obesity, dyslipidaemia, dysglycaemia) or MetS associated abnormalities not included in MetS diagnostic criteria (renal dysfunction, hyperuricaemia, hypercoaglutability, menopause, non alcoholic fatty liver disease, and obstructive sleep apnea) have been implicated too. We discuss the evidence connecting these cardio-metabolic risk factors, which negatively affect AS and finally increase CVD risk. Furthermore, we discuss the impact of possible lifestyle and pharmacological interventions on all these cardio-metabolic risk factors, in an effort to reduce CVD risk and identify features that should be taken into consideration when treating MetS patients with or without arterial hypertension.
Keywords: metabolic syndrome; arterial stiffness; central aortic pressure; arterial hypertension; cardiovascular disease; type 2 diabetes mellitus; chronic kidney disease; hyperuricaemia; non alcoholic fatty liver disease; obstructive sleep apnea metabolic syndrome; arterial stiffness; central aortic pressure; arterial hypertension; cardiovascular disease; type 2 diabetes mellitus; chronic kidney disease; hyperuricaemia; non alcoholic fatty liver disease; obstructive sleep apnea
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Athyros, V.G.; Reklou, A.; Lazarides, A.; Mitsiou, E.; Karagiannis, A. Effect of Cardio-Metabolic Risk Factors Clustering with or without Arterial Hypertension on Arterial Stiffness: A Narrative Review. Diseases 2013, 1, 51-72.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top